Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Medroxyprogesterone for uterine polyps in women
IRCT20250225064853N5Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Nov 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of medroxyprogesterone acetate in endometrial polyp (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Uterine polyp size, Endometrial thickness and 1 more. Started Nov 2025; status: completed.
02
Drugs
medroxyprogesterone acetate
03
Conditions
endometrial polyp
Beyond the preview
Go deeper on IRCT20250225064853N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250225064853N5.